Healthcare [ 13/13 ] | Drug Manufacturers - Specialty & Generic [ 77/161 ]
NASDAQ | Common Stock
| Reported Date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Feb 29, 24 | 1 Increased by +31.58% | 0.86 Increased by +16.28% |
| Nov 8, 23 | 1.27 Increased by +98.44% | 0.84 Increased by +51.19% |
| Aug 9, 23 | 1.28 Increased by +884.62% | 0.68 Increased by +88.24% |
| May 8, 23 | 1.17 Increased by +1.07 K% | 0.35 Increased by +234.29% |
| Mar 9, 23 | 0.76 Increased by +40.74% | 0.67 Increased by +13.43% |
| Nov 9, 22 | 0.64 Decreased by -36.63% | 0.55 Increased by +16.36% |
| Aug 8, 22 | 0.13 Decreased by -80.6% | 0.22 Decreased by -40.91% |
| May 10, 22 | -0.12 Decreased by -111.54% | 0.09 Decreased by -233.33% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 23 | 131.83 M Increased by +57.27% | 9.94 M Increased by +215.58% | Increased by +7.54% Increased by +173.49% |
| Jun 30, 23 | 116.55 M Increased by +57.81% | 6.25 M Increased by +141.85% | Increased by +5.36% Increased by +126.52% |
| Mar 31, 23 | 106.79 M Increased by +65.62% | 1.44 M Increased by +107.15% | Increased by +1.35% Increased by +104.32% |
| Dec 31, 22 | 94.23 M Increased by +54.66% | -4.24 M Increased by +82.42% | Decreased by -4.5% Increased by +88.63% |
| Sep 30, 22 | 83.82 M Increased by +61.01% | -8.6 M Decreased by -93.39% | Decreased by -10.26% Decreased by -20.11% |
| Jun 30, 22 | 73.86 M Increased by +51.89% | -14.92 M Decreased by -5.79% | Decreased by -20.21% Increased by +30.35% |
| Mar 31, 22 | 64.48 M Increased by +18.26% | -20.13 M Decreased by -23.51 K% | Decreased by -31.22% Decreased by -19.89 K% |
| Dec 31, 21 | 60.93 M Increased by +6.42% | -24.14 M Decreased by -563.99% | Decreased by -39.61% Decreased by -523.92% |
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.